Snapshot

DOI:

Effects of age on microvascular function; clinical value of a resistance index in stable angina; vulnerable plaques and adverse events; viewpoints and original research on left atrial appendage occlusion including long-term durability data of the Amplatzer Amulet; and more

From perspectives on left atrial appendage occlusions or original research on the effects of ageing or diabetes and vulnerable plaque to chimney/snorkel stenting during TAV-in-TAV – there’s something for everyone in this issue of EuroIntervention...take a look.

Effects of age on microvascular function

Tijn P.J. Jansen, Peter Damman and colleagues use continuous thermodilution to assess whether age has an effect on microvascular function in patients with normal coronary arteries. They demonstrate an age-dependent increase in hyperaemic microvascular resistance and a decrease in microvascular function, with the latter most evident in patients with smooth coronary arteries.

Clinical value of HSR in stable angina

By using the combined assessment of pressure and flow, the hyperaemic stenosis resistance index may overcome some of the limitations of conventional physiological indices. Vulnerable plaque features and adverse events confirm that hyperaemic stenosis resistance improves the diagnostic accuracy of the detection of ischaemia-inducing lesions and has an important prognostic value for the long-term risk of target vessel failure.

Vulnerable plaque features and adverse events

David del Val, Elvin Kedhi and colleagues examine the prognostic impact of optical coherence tomography-detected vulnerability features (OCT-VFs), either individually or in combination, in predicting the incidence of the lesion-oriented composite endpoint (LOCE) in diabetic patients with non- ischaemic lesions. Thin-cap fibroatheroma was the strongest single predictor of future LOCE events but the risk increased significantly with the simultaneous presence of four OCT-VFs.

Long-term LAAO safety with the Amplatzer Amulet

Lasse Hubertus Tiroke, Jens Erik Nielsen- Kudsk and colleagues evaluate the long- term safety and durability of the Amplatzer Amulet device after left atrial appendage occlusion. Their results suggest that the prevalence and size of peridevice leakage remain stable over time and rarely seal up or progress, underlining the importance of the immediate procedural outcome.

Volume 20 Number 11
Jun 3, 2024
Volume 20 Number 11
View full issue

Suggested by Cory

Expert Review

10.4244/EIJ-D-25-00201 Oct 10, 2025
Drug-coated balloons for coronary bifurcation lesions
Fezzi S et al
free

Editorial

10.4244/EIJ-E-25-00040 Oct 6, 2025
Photon-counting computed tomography for stent assessment
Andreini D and Di Mario C
free

Editorial

10.4244/EIJ-E-25-00042 Oct 6, 2025
Seeing is believing
Daemen J and Sadowski K
free

Editorial

10.4244/EIJ-E-25-00044 Oct 6, 2025
Just tap it in... stent optimisation in TAVI
Mylotte D and Thaddeus Soh B
free

Research Correspondence

10.4244/EIJ-D-25-00139 Oct 6, 2025
In-depth, patient-level analysis of clinical events in the NOTION-2 trial
Khokhar A et al

Flashlight

10.4244/EIJ-D-24-01165 Oct 6, 2025
Transcatheter tricuspid valve-in-ring following bicaval valve degeneration
Asmarats L et al

Original Research

10.4244/EIJ-D-25-00307 Oct 6, 2025
Impact of clinical risk characteristics on the prognostic value of high-risk plaques
Volleberg R et al
Trending articles
318.3

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
108.3

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
96.8

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
91.6

Image – Interventional flashlight

10.4244/EIJ-D-22-00344 Aug 5, 2022
First dedicated transcatheter leaflet splitting device: the ShortCut device
Tchétché D et al
free
67.55

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
56.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved